Cargando…
Relationship of left ventricular outflow tract velocity time integral to treatment strategy in submassive and massive pulmonary embolism
Pulmonary embolism is associated with high rates of mortality and morbidity. It is important to understand direct comparisons of current interventions to differentiate favorable outcomes and complications. The objective of this study was to compare ultrasound-accelerated thrombolysis versus systemic...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534090/ https://www.ncbi.nlm.nih.gov/pubmed/33062260 http://dx.doi.org/10.1177/2045894020953724 |
_version_ | 1783590250622222336 |
---|---|
author | Antoine, David Chuich, Taylor Mylvaganam, Ruben Malaisrie, Chris Freed, Benjamin Cuttica, Michael Schimmel, Daniel |
author_facet | Antoine, David Chuich, Taylor Mylvaganam, Ruben Malaisrie, Chris Freed, Benjamin Cuttica, Michael Schimmel, Daniel |
author_sort | Antoine, David |
collection | PubMed |
description | Pulmonary embolism is associated with high rates of mortality and morbidity. It is important to understand direct comparisons of current interventions to differentiate favorable outcomes and complications. The objective of this study was to compare ultrasound-accelerated thrombolysis versus systemic thrombolysis versus anticoagulation alone and their effect on left ventricular outflow tract velocity time integral. This was a retrospective cohort study of subjects ≥18 years of age with a diagnosis of submassive or massive pulmonary embolism. The primary outcome was the percent change in left ventricular outflow tract velocity time integral between pre- and post-treatment echocardiograms. Ultrasound-accelerated thrombolysis compared to anticoagulation had a greater improvement in left ventricular outflow tract velocity time integral, measured by percent change. No significant change was noted between the ultrasound-accelerated thrombolysis and systemic thrombolysis nor systemic thrombolysis and anticoagulation groups. Pulmonary artery systolic pressure only showed a significant reduction in the ultrasound-accelerated thrombolysis versus anticoagulation group. The percent change of right ventricular to left ventricular ratios was improved when systemic thrombolysis was compared to both ultrasound-accelerated thrombolysis and anticoagulation. In this retrospective study of submassive or massive pulmonary embolisms, left ventricular outflow tract velocity time integral demonstrated greater improvement in patients treated with ultrasound-accelerated thrombolysis as compared to anticoagulation alone, a finding not seen with systemic thrombolysis. While this improvement in left ventricular outflow tract velocity time integral parallels the trend seen in mortality outcomes across the three groups, it only correlates with changes seen in pulmonary artery systolic pressure, not in other markers of echocardiographic right ventricular dysfunction (tricuspid annular plane systolic excursion and right ventricular to left ventricular ratios). Changes in left ventricular outflow tract velocity time integral, rather than echocardiographic markers of right ventricular dysfunction, may be considered a more useful prognostic marker of both dysfunction and improvement after reperfusion therapy. |
format | Online Article Text |
id | pubmed-7534090 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-75340902020-10-14 Relationship of left ventricular outflow tract velocity time integral to treatment strategy in submassive and massive pulmonary embolism Antoine, David Chuich, Taylor Mylvaganam, Ruben Malaisrie, Chris Freed, Benjamin Cuttica, Michael Schimmel, Daniel Pulm Circ Research Article Pulmonary embolism is associated with high rates of mortality and morbidity. It is important to understand direct comparisons of current interventions to differentiate favorable outcomes and complications. The objective of this study was to compare ultrasound-accelerated thrombolysis versus systemic thrombolysis versus anticoagulation alone and their effect on left ventricular outflow tract velocity time integral. This was a retrospective cohort study of subjects ≥18 years of age with a diagnosis of submassive or massive pulmonary embolism. The primary outcome was the percent change in left ventricular outflow tract velocity time integral between pre- and post-treatment echocardiograms. Ultrasound-accelerated thrombolysis compared to anticoagulation had a greater improvement in left ventricular outflow tract velocity time integral, measured by percent change. No significant change was noted between the ultrasound-accelerated thrombolysis and systemic thrombolysis nor systemic thrombolysis and anticoagulation groups. Pulmonary artery systolic pressure only showed a significant reduction in the ultrasound-accelerated thrombolysis versus anticoagulation group. The percent change of right ventricular to left ventricular ratios was improved when systemic thrombolysis was compared to both ultrasound-accelerated thrombolysis and anticoagulation. In this retrospective study of submassive or massive pulmonary embolisms, left ventricular outflow tract velocity time integral demonstrated greater improvement in patients treated with ultrasound-accelerated thrombolysis as compared to anticoagulation alone, a finding not seen with systemic thrombolysis. While this improvement in left ventricular outflow tract velocity time integral parallels the trend seen in mortality outcomes across the three groups, it only correlates with changes seen in pulmonary artery systolic pressure, not in other markers of echocardiographic right ventricular dysfunction (tricuspid annular plane systolic excursion and right ventricular to left ventricular ratios). Changes in left ventricular outflow tract velocity time integral, rather than echocardiographic markers of right ventricular dysfunction, may be considered a more useful prognostic marker of both dysfunction and improvement after reperfusion therapy. SAGE Publications 2020-09-28 /pmc/articles/PMC7534090/ /pubmed/33062260 http://dx.doi.org/10.1177/2045894020953724 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research Article Antoine, David Chuich, Taylor Mylvaganam, Ruben Malaisrie, Chris Freed, Benjamin Cuttica, Michael Schimmel, Daniel Relationship of left ventricular outflow tract velocity time integral to treatment strategy in submassive and massive pulmonary embolism |
title | Relationship of left ventricular outflow tract velocity time integral to treatment strategy in submassive and massive pulmonary embolism |
title_full | Relationship of left ventricular outflow tract velocity time integral to treatment strategy in submassive and massive pulmonary embolism |
title_fullStr | Relationship of left ventricular outflow tract velocity time integral to treatment strategy in submassive and massive pulmonary embolism |
title_full_unstemmed | Relationship of left ventricular outflow tract velocity time integral to treatment strategy in submassive and massive pulmonary embolism |
title_short | Relationship of left ventricular outflow tract velocity time integral to treatment strategy in submassive and massive pulmonary embolism |
title_sort | relationship of left ventricular outflow tract velocity time integral to treatment strategy in submassive and massive pulmonary embolism |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534090/ https://www.ncbi.nlm.nih.gov/pubmed/33062260 http://dx.doi.org/10.1177/2045894020953724 |
work_keys_str_mv | AT antoinedavid relationshipofleftventricularoutflowtractvelocitytimeintegraltotreatmentstrategyinsubmassiveandmassivepulmonaryembolism AT chuichtaylor relationshipofleftventricularoutflowtractvelocitytimeintegraltotreatmentstrategyinsubmassiveandmassivepulmonaryembolism AT mylvaganamruben relationshipofleftventricularoutflowtractvelocitytimeintegraltotreatmentstrategyinsubmassiveandmassivepulmonaryembolism AT malaisriechris relationshipofleftventricularoutflowtractvelocitytimeintegraltotreatmentstrategyinsubmassiveandmassivepulmonaryembolism AT freedbenjamin relationshipofleftventricularoutflowtractvelocitytimeintegraltotreatmentstrategyinsubmassiveandmassivepulmonaryembolism AT cutticamichael relationshipofleftventricularoutflowtractvelocitytimeintegraltotreatmentstrategyinsubmassiveandmassivepulmonaryembolism AT schimmeldaniel relationshipofleftventricularoutflowtractvelocitytimeintegraltotreatmentstrategyinsubmassiveandmassivepulmonaryembolism |